← Back to all signals
RESEARCH PAPER ANALYSIS

Global, regional, and national burden of trachea, bronchus, and lung cancer among women of reproductive age, 1990-2019.

AI interpretation is pending for this paper.

Open original publication →
PMID38815483
JournalCancer epidemiology
Publication Date2024-05-29
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Trachea, bronchus, and lung (TBL) cancer has demonstrated a discernible feminization and a tendency towards younger onset in recent decades. Therefore, our objective is to examine the most recent patterns in the worldwide prevalence of TBL among women of reproductive age on a global, regional, and national scale. METHODS: To assess the prevalence trends of TBL in women of reproductive age, we calculated the estimated annual percentage change (EAPC), age-standardized incidence rate (ASIR), age-standardized death rate (ASDR), and disability-adjusted life years (DALYs) for 204 countries and territories from 1990 to 2019. These calculations were based on the Global Burden of Disease (GBD) 2019 database. RESULTS: From 1990 to 2019, there was a global increase in the absolute number of incidence cases, deaths, and DALYs of TBL in women of reproductive age. However, the ASIR, ASDR, and age-standardized DALY rates were decreasing over this period, with EAPC of -0.77 (95 % confidence interval [CI]: -1.03 to -0.51), -1.08 (95 % CI: -1.34 to -0.82), and -1.10 (95 % CI: -1.36 to -0.84), respectively. This trend was observed even in regions with higher Socio-Demographic Index (SDI). East Asia consistently had the highest ASIR, ASDR, and age-standardized DALY rate, but there was a decreasing trend. Conversely, Eastern Sub-Saharan Africa displayed an increasing burden pattern. When examining countries individually, Monaco, Greenland, and Palau had the highest ASIR. Moreover, in most countries, the ASIR for TBL increased with age, particularly among women aged 35-49 years. CONCLUSIONS: Despite a global decline in ASIR, ASDR, and age-standardized DALY rates for TBL in women of reproductive age over the past three decades, there is still a troubling increase observed in low- and low-middle SDI regions. It is crucial to implement effective preventive and curative measures in these regions in order to address this concerning trend.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Potentially Clinically Beneficial Interactions Between Biologically-Based Complementary Medicines and Cancer Treatment: A Systematic Scoping Review. Integrative cancer therapies 87.24 2 RAS inhibition limits oncogenic signaling and tumorigenesis in neuroblastoma regardless of RAS mutational status. Scientific reports 53.7 3 A de novo IKZF4 Variant Underlies Hypogammaglobulinemia and Increased Infection Susceptibility through Downregulating the NF-κB Pathway. Journal of clinical immunology 51.0 4 The impact of chemotherapy on frontal lobe executive functioning in adolescents and young adults diagnosed and treated for blood cancers: a systematic review. BMC cancer 77.14 5 Cutaneous angiomyolipoma presenting as a pilonidal cyst: a case report. Journal of medical case reports 45.5 6 Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study. Orphanet journal of rare diseases 65.0 7 A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance. Cellular oncology (Dordrecht, Netherlands) 57.2 8 Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. Cytotherapy 71.7 9 [Testicular leukemia and its treatment in prepubertal males: An update]. Zhonghua nan ke xue = National journal of andrology 68.84 10 Beyond Depression: Suicidality As the First Clue to a Silent Brain Tumor in the Elderly. Cureus 47.5 11 An Atypical Case of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis With Isolated Lower Airway Involvement in a Young Adult. Cureus 58.56 12 Indoor radon monitoring through citizen science in Catalan schools: environmental assessment and educational outcomes. Frontiers in public health 59.5 13 Diet meets biologics: accelerating remission in pediatric Crohn's disease - a real-world experience. Frontiers in gastroenterology (Lausanne, Switzerland) 69.76 14 Dyadic associations between perceived family resilience and fear of disease progression among reproductive-age patients with cervical cancer and their spouses: a cross-sectional study. Frontiers in oncology 64.0 15 Bone marrow CD14+CD206+ M2-like monocyte-macrophages as a potential complementary biomarker for bone marrow MRD in high-risk neuroblastoma. Frontiers in oncology 63.75 16 Comparative analysis of respiratory infection and clinical outcomes in Saudi hematology: malignant versus non-malignant cohorts. Frontiers in cellular and infection microbiology 57.2 17 Assessment of computational methods for fusion transcript detection in targeted RNA-seq samples. Frontiers in bioinformatics 56.0 18 The golden hour: the feasibility of a quality improvement project to decrease the time to antibiotic administration in children with cancer and febrile neutropenia in Jordan. Frontiers in pediatrics 67.9 19 Human models for human diseases: how pluripotent stem cell derived brain organoids can help us understand and treat diffuse hemispheric glioma. Frontiers in cell and developmental biology 50.0 20 Therapeutic enhancement and toxicity reduction of total glucosides of paeony combined with conventional therapy in juvenile idiopathic arthritis: a meta-analysis and network pharmacology. Frontiers in pediatrics 89.7 21 Single-stage combined cardiac and abdominal wall reconstruction in Pentalogy of Cantrell using a cemented sandwich mesh technique: a case report. Frontiers in pediatrics 51.0 22 Metabolic reprogramming in the immune microenvironment of Ewing sarcoma: from mechanisms to therapeutic strategies. Frontiers in immunology 75.5 23 Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease-Free Survival in Osteosarcoma Patients. Cancer medicine 68.62 24 Paediatric Bone Marrow Transplant Outcomes. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 60.7 25 The Hidden Burden: Addressing Disparities in Childhood Cancer Incidence Trends. Cancer reports (Hoboken, N.J.) 38.6 26 Geographic patterns of platform-reported pediatric major-disease cases and healthcare inequality in China: spatial associations and cross-regional healthcare seeking. International journal for equity in health 67.9 27 Carcinoembryonic antigen (CEA) is a useful screening biomarker for inherited glycosylphosphatidylinositol deficiencies. Molecular genetics and metabolism 58.35 28 Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan. Clinical case reports 56.3 29 Physiological Uterine Uptake of 18F-MFBG During Menstruation in a Pediatric Patient With Neuroblastoma. Clinical nuclear medicine 68.6 30 ATRT and ETMR: distinct tumors, shared clinical challenges-a comparative narrative review. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 72.1 31 A Comprehensive Radiomics Model for Predicting Progression-Free Survival in High-Risk Neuroblastoma Based on CT Imaging. The British journal of radiology 57.62 32 Response to comment on: "Immune checkpoint therapy in pediatric and adolescent lymphomas". Haematologica 52.36
PATIENT-FRIENDLY SUMMARY

Global, regional, and national burden of trachea, bronchus, and lung cancer among women of reproductive age, 1990-2019.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic